• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌免疫微环境景观及其对组织学和分子分类的附加影响。

Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification.

机构信息

Department of Pathology, Keio University School of Medicine, Tokyo, Japan.

Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

出版信息

Hepatology. 2018 Sep;68(3):1025-1041. doi: 10.1002/hep.29904. Epub 2018 Jul 25.

DOI:10.1002/hep.29904
PMID:29603348
Abstract

UNLABELLED

Immune cells constitute an important element of tumor tissue. Accumulating evidence indicates their clinicopathological significance in predicting prognosis and therapeutic efficacy. Nonetheless, the combinations of immune cells forming the immune microenvironment and their association with histological findings remain largely unknown. Moreover, it is unclear which immune cells or immune microenvironments are the most prognostically significant. Here, we comprehensively analyzed the immune microenvironment and its intratumor heterogeneity in 919 regions of 158 hepatocellular carcinomas (HCCs), and the results were compared with the corresponding histological and prognostic data. Consequently, we classified the immune microenvironment of HCC into three distinct immunosubtypes: Immune-high, Immune-mid, and Immune-low. The Immune-high subtype was characterized by increased B-/plasma-cell and T cell infiltration, and the Immune-high subtype and B-cell infiltration were identified as independent positive prognostic factors. Varying degrees of intratumor heterogeneity of the immune microenvironment were observed, some of which reflected the multistep nature of HCC carcinogenesis. However, the predominant pattern of immunosubtype and immune cell infiltration of each tumor was prognostically important. Of note, the Immune-high subtype was associated with poorly differentiated HCC, cytokeratin 19 (CK19) , and/or Sal-like protein 4 (SALL4) high-grade HCC, and Hoshida's S1/Boyault's G2 subclasses. Furthermore, patients with high-grade HCC of the predominant Immune-high subtype had significantly better prognosis. These results provide a rationale for evaluating the immune microenvironment in addition to the usual histological/molecular classification of HCC.

CONCLUSION

The immune microenvironment of HCC can be classified into three immunosubtypes (Immune-high, Immune-mid, and Immune-low) with additional prognostic impact on histological and molecular classification of HCC. (Hepatology 2018).

摘要

未加标签

免疫细胞是肿瘤组织的重要组成部分。越来越多的证据表明,它们在预测预后和治疗效果方面具有临床病理意义。尽管如此,构成免疫微环境的免疫细胞组合及其与组织学发现的关系在很大程度上仍然未知。此外,目前尚不清楚哪些免疫细胞或免疫微环境对预后意义最大。在这里,我们全面分析了 158 例肝细胞癌(HCC)的 919 个区域的免疫微环境及其肿瘤内异质性,并将结果与相应的组织学和预后数据进行了比较。因此,我们将 HCC 的免疫微环境分为三种不同的免疫亚型:免疫高、免疫中和免疫低。免疫高亚型的特征是 B-/浆细胞和 T 细胞浸润增加,免疫高亚型和 B 细胞浸润被确定为独立的阳性预后因素。观察到免疫微环境的肿瘤内异质性程度不同,其中一些反映了 HCC 癌变的多步骤性质。然而,每个肿瘤的免疫亚型和免疫细胞浸润的主要模式对预后具有重要意义。值得注意的是,免疫高亚型与分化差的 HCC、细胞角蛋白 19(CK19)和/或 Slike 蛋白 4(SALL4)高级别 HCC 以及 Hoshida 的 S1/Boyault 的 G2 亚类相关。此外,主要为免疫高亚型的高级别 HCC 患者的预后明显更好。这些结果为评估免疫微环境提供了依据,除了 HCC 的常规组织学/分子分类之外。

结论

HCC 的免疫微环境可分为三种免疫亚型(免疫高、免疫中和免疫低),对 HCC 的组织学和分子分类具有额外的预后影响。(Hepatology 2018)。

相似文献

1
Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification.肝细胞癌免疫微环境景观及其对组织学和分子分类的附加影响。
Hepatology. 2018 Sep;68(3):1025-1041. doi: 10.1002/hep.29904. Epub 2018 Jul 25.
2
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features.基于分子特征鉴定免疫特异的肝细胞癌。
Gastroenterology. 2017 Sep;153(3):812-826. doi: 10.1053/j.gastro.2017.06.007. Epub 2017 Jun 15.
3
Reliability of a single-region sample to evaluate tumor immune microenvironment in hepatocellular carcinoma.单区域样本评估肝细胞癌肿瘤免疫微环境的可靠性。
J Hepatol. 2020 Mar;72(3):489-497. doi: 10.1016/j.jhep.2019.09.032. Epub 2019 Oct 18.
4
Sarcomatoid hepatocellular carcinoma is distinct from ordinary hepatocellular carcinoma: Clinicopathologic, transcriptomic and immunologic analyses.肉瘤样肝细胞癌有别于普通肝细胞癌:临床病理、转录组学和免疫分析。
Int J Cancer. 2021 Aug 1;149(3):546-560. doi: 10.1002/ijc.33545. Epub 2021 Mar 13.
5
VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma.VISTA 表达与 CD8 相关,可赋予肝癌有利的免疫微环境和更好的总生存。
BMC Cancer. 2018 May 2;18(1):511. doi: 10.1186/s12885-018-4435-1.
6
Immunovascular classification of HCC reflects reciprocal interaction between immune and angiogenic tumor microenvironments.肝癌的免疫血管分类反映了免疫和血管生成肿瘤微环境之间的相互作用。
Hepatology. 2022 May;75(5):1139-1153. doi: 10.1002/hep.32201. Epub 2021 Dec 12.
7
Identification of immunological subtypes of hepatocellular carcinoma with expression profiling of immune-modulating genes.基于免疫调节基因表达谱鉴定肝癌的免疫亚型。
Aging (Albany NY). 2020 Jun 16;12(12):12187-12205. doi: 10.18632/aging.103395.
8
Dimensions of hepatocellular carcinoma phenotypic diversity.肝细胞癌表型多样性的维度。
World J Gastroenterol. 2018 Oct 28;24(40):4536-4547. doi: 10.3748/wjg.v24.i40.4536.
9
Upregulation of B7-H1 expression is associated with macrophage infiltration in hepatocellular carcinomas.B7-H1 表达上调与肝癌中的巨噬细胞浸润有关。
Cancer Immunol Immunother. 2012 Jan;61(1):101-8. doi: 10.1007/s00262-011-1094-3. Epub 2011 Aug 19.
10
Prognostic value of CMTM6 protein in hepatocellular carcinoma involving the regulation of the immune microenvironment.CMTM6 蛋白在肝细胞癌中的预后价值及其对免疫微环境的调控。
Int J Biol Macromol. 2024 Aug;275(Pt 2):133618. doi: 10.1016/j.ijbiomac.2024.133618. Epub 2024 Jul 5.

引用本文的文献

1
Responsive biomaterials for therapeutic strategies of hepatocellular carcinoma.用于肝细胞癌治疗策略的响应性生物材料
Front Bioeng Biotechnol. 2025 Aug 20;13:1673134. doi: 10.3389/fbioe.2025.1673134. eCollection 2025.
2
Immunological Landscape and Molecular Therapeutic Targets of the Tumor Microenvironment in Hepatocellular Carcinoma.肝细胞癌肿瘤微环境的免疫格局与分子治疗靶点
Int J Mol Sci. 2025 Aug 13;26(16):7836. doi: 10.3390/ijms26167836.
3
Progression to fibrosis and hepatocellular carcinoma in DEN CCl liver mice, is associated with macrophage and striking regulatory T cells infiltration.
在二乙基亚硝胺(DEN)-四氯化碳(CCl)诱导的肝纤维化小鼠模型中,向纤维化和肝细胞癌的进展与巨噬细胞及显著的调节性T细胞浸润有关。
Front Immunol. 2025 Jul 8;16:1601215. doi: 10.3389/fimmu.2025.1601215. eCollection 2025.
4
Tumor-immune Co-evolution in hepatocellular carcinoma and its implication for immunotherapy resistance.肝细胞癌中的肿瘤-免疫共同进化及其对免疫治疗耐药性的影响。
ILIVER. 2022 Mar 9;1(1):78-80. doi: 10.1016/j.iliver.2022.02.003. eCollection 2022 Mar.
5
Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Features Can Predict Immune-Excluded Phenotype of Hepatocellular Carcinoma.钆塞酸二钠增强磁共振成像特征可预测肝细胞癌的免疫排除表型。
Liver Cancer. 2024 Nov 13;14(3):271-285. doi: 10.1159/000542099. eCollection 2025 Jun.
6
Identification of metabolism-associated molecular classification for effect and prognosis in lung adenocarcinoma based on multidatabases including the cancer genome atlas and gene expression omnibus.基于包括癌症基因组图谱和基因表达综合数据库在内的多数据库鉴定肺腺癌中与代谢相关的分子分类对疗效和预后的影响
SAGE Open Med. 2025 Jun 14;13:20503121251341114. doi: 10.1177/20503121251341114. eCollection 2025.
7
Genetically predicted immune cells mediates the association between hepatocellular carcinoma and inflammatory proteins: a Mendelian randomization study.基因预测的免疫细胞介导肝细胞癌与炎症蛋白之间的关联:一项孟德尔随机化研究。
Discov Oncol. 2025 Jun 12;16(1):1065. doi: 10.1007/s12672-025-02805-8.
8
To determine the role of TRIT1 in the diagnosis, prognosis and immunoinvasion of liver hepatocellular carcinoma.确定TRIT1在肝细胞癌的诊断、预后及免疫侵袭中的作用。
Front Immunol. 2025 May 5;16:1563442. doi: 10.3389/fimmu.2025.1563442. eCollection 2025.
9
Novel immune-related prognostic models for patients with hepatocellular carcinoma after curative resection.肝细胞癌根治性切除术后患者的新型免疫相关预后模型。
Hepatol Int. 2025 May 15. doi: 10.1007/s12072-025-10839-x.
10
An elevated percentage of CD4⁺CD25⁺CD127 regulatory T cells in peripheral blood indicates a poorer prognosis in hepatocellular carcinoma after curative hepatectomy.外周血中CD4⁺CD25⁺CD127调节性T细胞比例升高表明肝细胞癌根治性肝切除术后预后较差。
BMC Gastroenterol. 2025 May 7;25(1):340. doi: 10.1186/s12876-025-03940-w.